购物车
- 全部删除
- 您的购物车当前为空
Simufilam 是一种低毒,口服的 filamin A (FLNA) 激活剂。Simufilam 优先结合大脑中改变的FLNA,恢复其天然构象,恢复受体和突触活性,并减少其与 a7nAChR/TLR4 的关联和下游病理作用。Simufilam 可用于阿尔茨海默症的研究。
Simufilam 是一种低毒,口服的 filamin A (FLNA) 激活剂。Simufilam 优先结合大脑中改变的FLNA,恢复其天然构象,恢复受体和突触活性,并减少其与 a7nAChR/TLR4 的关联和下游病理作用。Simufilam 可用于阿尔茨海默症的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 mg | ¥ 10,996 | 6-8周 | |
200 mg | ¥ 16,625 | 6-8周 |
产品描述 | Simufilam (PTI-125) is a low toxicity, orally active filamin A ( FLNA ) activator. Simufilam preferentially binds altered FLNA and restores its native conformation, restores receptor and synaptic activities, reduces its a7nAChR/TLR4 associations and downstream pathologies. Simufilam can be used in Alzheimer's disease research[1]. |
体外活性 | Simufilam (1 pM~1 nM) dose-dependently improves Arc expression induced by NMDA/glycine[1]. Simufilam (1 nM, 1 hour) largely restores filamin A to its native conformation and is effective in normalizing receptor activities in AD frontal cortices. Simufilam dose-dependently reduces Ab42-induced FLNA coupling to a7nAChR and TLR4 in both Ab42-treated control and AD hippocampus. Simufilam reduces Ab42's binding affinity for a7nAChR, thereby prevents Ab42's signaling and further accumulation on a7nAChRs [1]. |
体内活性 | Simufilam (P.o.; 2 months) restores FLNA to its native conformation. Simufilam (22 mg/kg; p.o.) strongly reduces FLNAea7nAChR/TLR4 associations. Simufilam significantly improves spatial memory. Simufilam significantly improves working memory [1]. |
分子量 | 259.35 |
分子式 | C15H21N3O |
CAS No. | 1224591-33-6 |
密度 | 1.18 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容